Mometasone Furoate News
Mometasone Furoate currently has 0 news articles, with 20 predicted indications.
This page combines the AI-predicted indications for Mometasone Furoate with the latest health news. Indications highlighted in orange have recent news coverage.
Drug Information
- Original indication: Bemrist Breezhaler is indicated as a maintenance treatment of asthma in adults and adolescents 12 years of age and older not adequately controlled with inhaled corticosteroids and inhaled short...
- Evidence level: L5
- Predicted indications (20):
- atopic eczema (99.7%)
- dermatitis, atopic (99.3%)
- 2-hydroxyethyl methacrylate sensitization (98.6%)
- seborrheic dermatitis (98.1%)
- polyp of vocal cord (97.7%)
- polyp of middle ear (97.7%)
- polyp of frontal sinus (97.6%)
- polyp of external auditory canal (97.5%)
- fibroepithelial polyp (97.5%)
- polyp of vulva (97.5%)
- polyp of ureter (97.5%)
- epulis (97.5%)
- neoplastic polyp (97.5%)
- uterine polyp (97.5%)
- primary cutaneous T-cell non-Hodgkin lymphoma (97.3%)
- alopecia mucinosa (97.2%)
- alopecia areata (97.1%)
- telogen effluvium (97.0%)
- Quinquaud's folliculitis decalvans (96.7%)
- seborrheic keratosis (96.6%)
Related News (0)
No related news yet. When news mentions this drug, it will be collected and shown here automatically.
Disclaimer: The news on this page is collected automatically and is for research reference only; it does not constitute medical advice.